Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes.
Taishi NakaseGeno A GuerraQuinn T OstromTian GeBeatrice MelinMargaret WrenschJohn K WienckeRobert B JenkinsJeanette E Eckel-Passownull nullMelissa L BondyStephen S FrancisLinda KachuriPublished in: medRxiv : the preprint server for health sciences (2024)
Our novel genome-wide PRS may improve the identification of high-risk individuals and help distinguish between prognostic glioma subtypes, increasing the potential clinical utility of germline genetics in glioma patient management.